Details for Patent: 11,286,488
✉ Email this page to a colleague
Which drugs does patent 11,286,488 protect, and when does it expire?
Patent 11,286,488 protects RIVFLOZA and is included in one NDA.
This patent has nineteen patent family members in fourteen countries.
Summary for Patent: 11,286,488
Title: | Methods and compositions for inhibiting expression of LDHA |
Abstract: | This disclosure relates to oligonucleotides, compositions and methods useful for reducing LDHA expression, particularly in hepatocytes. |
Inventor(s): | Brown Bob D., Dudek Henryk T., Saxena Utsav, Pursell Natalie, Lai Cheng, Wang Weimin, Storr Rachel, Nazef Naim, Kim Boyoung |
Assignee: | Dicerna Pharmaceuticals, Inc. |
Application Number: | US16755342 |
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 11,286,488
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novo | RIVFLOZA | nedosiran sodium | SOLUTION;INJECTION | 215842-001 | Sep 29, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | METHOD OF TREATING PRIMARY HYPEROXALURIA TYPE 1 (PH1) | ⤷ Sign Up | ||
Novo | RIVFLOZA | nedosiran sodium | SOLUTION;INJECTION | 215842-002 | Sep 29, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | METHOD OF TREATING PRIMARY HYPEROXALURIA TYPE 1 (PH1) | ⤷ Sign Up | ||
Novo | RIVFLOZA | nedosiran sodium | SOLUTION;INJECTION | 215842-003 | Sep 29, 2023 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | METHOD OF TREATING PRIMARY HYPEROXALURIA TYPE 1 (PH1) | ⤷ Sign Up | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,286,488
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2018346971 | ⤷ Sign Up | |||
Canada | 3078933 | ⤷ Sign Up | |||
China | 111448319 | ⤷ Sign Up | |||
European Patent Office | 3679141 | ⤷ Sign Up | |||
European Patent Office | 4265261 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |